Daily Roundup

BIO.ASX SEQ.ASX MCE.ASX ABV.ASX CCA.ASX

Biome Australia Delivers Record Sales and Profitability

Biome Australia Limited (ASX: BIO) has reported a stellar performance, with record quarterly and annual sales revenue. The company recorded $78k in EBITDA for Q4 and expects EBITDA to exceed $900k for the full FY25.

Biome's sales revenue reached new heights, with June sales up 50% year-over-year, Q4 sales up 33%, and annual sales up 41% to $18.4 million. The company expects to report its first full-year net profit for FY25, along with an impressive gross margin of 61%.

Looking ahead, Biome is optimistic about the future, with the launch of new Activated Therapeutics and Activated Probiotics products, as well as continued international expansion. The company expects Q1 FY26 to be another record-breaking quarter for sales revenue.

Sequoia Financial Pauses and Requests Trading Halt

In a surprising move, Sequoia Financial Group Ltd (ASX: SEQ) has announced a temporary pause in trading of its securities. The company has not provided any details on the reason for the trading pause, stating that a further announcement will be made.

Shortly after, Sequoia requested an immediate trading halt, pending the release of an announcement regarding a response to an ASX price query. The trading halt is expected to last until Sequoia provides its response to the ASX.

Matrix Awarded Major $35 Million Subsea Contract

Matrix Composites & Engineering Ltd (ASX: MCE) has secured a significant new contract, valued at approximately $35 million, for the supply and manufacture of subsea components for an international energy project.

The contract, awarded by a large multinational energy services contractor, will commence immediately, with production expected to start during the December 2025 quarter and completion by the end of the 2026 financial year. This new project demonstrates Matrix's continued success in the global market and its ability to secure major contracts with leading international clients.

Advanced Braking Technology Reports Robust Growth

Advanced Braking Technology Ltd (ASX: ABT) has delivered a strong performance, with significant growth in both sales revenue and profitability. The company recorded sales revenue of $5.6 million in Q4 FY25, up 27% year-over-year, and annual sales revenue of $18.7 million, also up 27%.

ABT's Reported NPAT for FY25 is expected to be $1.78 million, up 5% on the prior corresponding period, while its underlying NPAT (excluding R&D tax income rebate) is expected to be $1.08 million, up an impressive 87%.

The company's domestic and international operations both performed well, with a particular focus on growth in regions such as Indonesia, Mongolia, and Canada. ABT is optimistic about the future, with a strong pipeline of innovation and a strategic plan to drive sustainable growth.

Change Financial Delivers Record Quarter, Positive Outlook

Change Financial Limited (ASX: CCA) has reported a stellar Q4 FY25, with record revenue of US$4.0 million (A$6.2 million), up 26% year-over-year. The company's full-year revenue for FY25 reached US$15.1 million (A$23.2 million), a 42% increase from the previous year.

Change's Vertexon PaaS platform continued to scale, with over 73,000 active cards, up 133% year-over-year. The company also secured a new Vertexon PaaS client in Australia and New Zealand, as well as one-off sales with Vertexon On-Premises and PaySim clients.

Looking ahead, Change has provided positive FY26 guidance, expecting revenue in the range of US$16.5 million (A$25.4 million) to US$18.0 million (A$27.7 million) and Underlying EBITDA of US$2.5 million (A$3.8 million) to US$3.5 million (A$5.4 million). The company is also expected to be net cash flow positive for FY26.